Simplex Trading
TSHA icon

Simplex Trading’s Taysha Gene Therapies TSHA Stock Holding History

Simplex Trading’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
39,500
+13,500
+52% +$79.9K ﹤0.01% 4348
2026
Q1 		$116K Buy
26,000
+1,800
+7% +$8.37K ﹤0.01% 4911
2025
Q4 		$133K Buy
24,200
+13,700
+130% +$66.5K ﹤0.01% 4683
2025
Q3 		$34K Sell
10,500
-200
-2% -$566 ﹤0.01% 6856
2025
Q2 		$24K Buy
10,700
+8,100
+312% +$17.6K ﹤0.01% 6624
2025
Q1 		$3K Sell
2,600
-20,200
-89% -$33.8K ﹤0.01% 7893
2024
Q4 		$39K Buy
22,800
+22,300
+4,460% +$46.3K ﹤0.01% 6135
2024
Q3 		$1K Sell
500
-16,700
-97% -$36.6K ﹤0.01% 8291
2024
Q2 		$38K Buy
17,200
+5,900
+52% +$17.2K ﹤0.01% 6349
2024
Q1 		$32K Sell
11,300
-7,900
-41% -$16.5K ﹤0.01% 6710
2023
Q4 		$33K Sell
19,200
-400
-2% -$797 ﹤0.01% 6487
2023
Q3 		$61K Buy
+19,600
New +$36.6K ﹤0.01% 5630
2023
Q1 		– Sell
-27,200
Closed -$61K – 10155
2022
Q4 		$61K Buy
27,200
+25,800
+1,843% +$52.2K ﹤0.01% 5632
2022
Q3 		$2K Buy
1,400
+500
+56% +$1.81K ﹤0.01% 9373
2022
Q2 		$3K Buy
+900
New +$3.57K ﹤0.01% 9213

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's TSHA Position: Q2 2026 in Review

Simplex Trading opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 13,371 shares worth $91.1K. The stake represents ﹤0.01% of the portfolio and ranks #5670 among its holdings. This is a return to the name: Simplex Trading previously reported a position in TSHA as recently as Q4 2025.

Simplex Trading first reported a position in TSHA in Q4 2021 and has held it in 11 quarters since. The position peaked at $109K in Q4 2025. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Simplex Trading held 13,371 shares of Taysha Gene Therapies worth $91.1K as of Q2 2026.
  • Taysha Gene Therapies was a new Simplex Trading position in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5670 holding.
  • Simplex Trading first reported a position in Taysha Gene Therapies in Q4 2021 and has held it in 11 quarters since.
  • Simplex Trading's Taysha Gene Therapies position peaked at $109K in Q4 2025.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.